| |
| |
|
| Insider
Information: |
Schatzman Randall C |
| Relationship: |
Chief Executive Office... |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
116,672 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,175,582 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,672 |
|
|
| Total
Value |
$2,175,582 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -63.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alder Biopharmaceuticals Inc |
ALDR |
President and CEO, Dir... |
2017-02-09 |
115,172 |
|
0 |
Premium* |
|
|
Bolt Biotherapeutics, Inc. |
BOLT |
Chief Executive Office... |
2021-02-09 |
1,500 |
2021-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BOLT |
Bolt Biotherapeutics, Inc... |
Chief Executive Officer |
• • – |
2021-02-09 |
4 |
B |
$20.00 |
$30,000 |
D/D |
1,500 |
1,500 |
2.81 |
% |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2017-02-09 |
4 |
AS |
$25.03 |
$750,756 |
D/D |
(30,000) |
115,172 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2017-02-09 |
4 |
OE |
$1.65 |
$49,500 |
D/D |
30,000 |
145,172 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-11-30 |
4 |
A |
$20.20 |
$8,161 |
D/D |
404 |
115,172 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-11-07 |
4 |
AS |
$25.16 |
$251,605 |
D/D |
(10,000) |
114,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-11-07 |
4 |
OE |
$1.65 |
$16,500 |
D/D |
10,000 |
124,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-10-03 |
4 |
AS |
$30.95 |
$254,811 |
D/D |
(8,181) |
114,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-10-03 |
4 |
OE |
$1.27 |
$10,349 |
D/D |
8,181 |
122,949 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-09-01 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-09-01 |
4 |
AS |
$32.48 |
$324,820 |
D/D |
(10,000) |
114,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-08-01 |
4 |
AS |
$30.65 |
$311,513 |
D/D |
(10,000) |
114,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-08-01 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-07-25 |
4 |
AS |
$28.08 |
$280,805 |
D/D |
(10,000) |
114,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-07-25 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-06-01 |
4 |
OE |
$1.27 |
$12,650 |
D/D |
10,000 |
124,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-06-01 |
4 |
AS |
$29.51 |
$296,544 |
D/D |
(10,000) |
114,768 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-05-24 |
4 |
AS |
$28.03 |
$112,588 |
D/D |
(4,017) |
112,947 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-05-24 |
4 |
OE |
$1.27 |
$5,082 |
D/D |
4,017 |
116,964 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-05-23 |
4 |
AS |
$28.01 |
$83,952 |
D/D |
(2,997) |
112,947 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-05-23 |
4 |
OE |
$1.27 |
$3,791 |
D/D |
2,997 |
115,944 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-05-20 |
4 |
AS |
$28.01 |
$83,635 |
D/D |
(2,986) |
112,947 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-05-20 |
4 |
OE |
$1.27 |
$3,777 |
D/D |
2,986 |
115,933 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-04-18 |
4 |
AS |
$28.08 |
$126,742 |
D/D |
(4,514) |
112,947 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-04-18 |
4 |
OE |
$1.27 |
$5,710 |
D/D |
4,514 |
117,461 |
0 |
- |
|
| ALDR |
Alder Biopharmaceuticals ... |
President and CEO |
• • – |
2016-04-15 |
4 |
AS |
$28.11 |
$394,150 |
D/D |
(14,024) |
112,947 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
